BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leccese G, Bibi A, Mazza S, Facciotti F, Caprioli F, Landini P, Paroni M. Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive Escherichia coli (AIEC) Virulence and Hamper IL-23/Th17 Axis in Ulcerative Colitis, but Not in Crohn's Disease. Cells 2020;9:E1824. [PMID: 32752244 DOI: 10.3390/cells9081824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Y, Yu Y, Chen XF, Yang SL, Tang XL, Xiang ZG. Intestinal Macrophage Autophagy and its Pharmacological Application in Inflammatory Bowel Disease. Front Pharmacol 2021;12:803686. [PMID: 34899362 DOI: 10.3389/fphar.2021.803686] [Reference Citation Analysis]
2 Saber S, Abd El-Fattah EE, Yahya G, Gobba NA, Maghmomeh AO, Khodir AE, Mourad AAE, Saad AS, Mohammed HG, Nouh NA, Shata A, Amin NA, Abou El-Rous M, Girgis S, El-Ahwany E, Khalaf EM, El-Kott AF, El-Baz AM. A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition. Pharmaceuticals (Basel) 2021;14:341. [PMID: 33917884 DOI: 10.3390/ph14040341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Mao Q, Pan H, Zhang Y, Zhang Y, Zhu Q, Hong Y, Huang Z, Li Y, Feng X, Fang Y, Chen W, Chen P, Shen B, Ouyang H, Liang Y. GelNB molecular coating as a biophysical barrier to isolate intestinal irritating metabolites and regulate intestinal microbial homeostasis in the treatment of inflammatory bowel disease. Bioactive Materials 2023;19:251-67. [DOI: 10.1016/j.bioactmat.2022.04.001] [Reference Citation Analysis]
4 Marion-Letellier R, Leboutte M, Amamou A, Raman M, Savoye G, Ghosh S. Diet in Intestinal Fibrosis: A Double-Edged Sword. Nutrients 2021;13:3148. [PMID: 34579023 DOI: 10.3390/nu13093148] [Reference Citation Analysis]
5 Antunes JC, Seabra CL, Domingues JM, Teixeira MO, Nunes C, Costa-Lima SA, Homem NC, Reis S, Amorim MTP, Felgueiras HP. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials (Basel) 2021;11:2035. [PMID: 34443866 DOI: 10.3390/nano11082035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ma J, Chen J, Xue K, Yu C, Dang E, Qiao H, Fang H, Pang B, Li Q, Sun Z, Qiao P, Wang L, Wang G, Shao S. Lipocalin 2 Mediates Skin Inflammation in Psoriasis via the SREBP2-NLRC4 Axis. J Invest Dermatol 2022:S0022-202X(22)00080-X. [PMID: 35120997 DOI: 10.1016/j.jid.2022.01.012] [Reference Citation Analysis]
7 Alkushi AG, Elazab ST, Abdelfattah-hassan A, Mahfouz H, Salem GA, Sheraiba NI, Mohamed EAA, Attia MS, El-shetry ES, Saleh AA, Elsawy NA, Ibrahim D. Multi-Strain-Probiotic-Loaded Nanoparticles Reduced Colon Inflammation and Orchestrated the Expressions of Tight Junction, NLRP3 Inflammasome and Caspase-1 Genes in DSS-Induced Colitis Model. Pharmaceutics 2022;14:1183. [DOI: 10.3390/pharmaceutics14061183] [Reference Citation Analysis]
8 Kye YJ, Lee SY, Kim HR, Lee BH, Park JH, Park MS, Ji GE, Sung MK. Lactobacillus acidophilus PIN7 paraprobiotic supplementation ameliorates DSS-induced colitis through anti-inflammatory and immune regulatory effects. J Appl Microbiol 2021. [PMID: 34878713 DOI: 10.1111/jam.15406] [Reference Citation Analysis]
9 Rossi E, Leccese G, Baldelli V, Bibi A, Scalone E, Camilloni C, Paroni M, Landini P. Inactivation of the Pyrimidine Biosynthesis pyrD Gene Negatively Affects Biofilm Formation and Virulence Determinants in the Crohn’s Disease-Associated Adherent Invasive Escherichia coli LF82 Strain. Microorganisms 2022;10:537. [DOI: 10.3390/microorganisms10030537] [Reference Citation Analysis]
10 Zhang D, Verstrepen L, De Medts J, Duysburgh C, Van den Abbeele P, Marzorati M, Khoo C. A Cranberry Concentrate Decreases Adhesion and Invasion of Escherichia coli (AIEC) LF82 In Vitro. Pathogens 2021;10:1217. [PMID: 34578249 DOI: 10.3390/pathogens10091217] [Reference Citation Analysis]
11 Shen H, Zhao Z, Zhao Z, Chen Y, Zhang L. Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases. Int J Mol Sci 2022;23:594. [PMID: 35054790 DOI: 10.3390/ijms23020594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
12 Yuan L, Chu B, Chen S, Li Y, Liu N, Zhu Y, Zhou D. Exopolysaccharides from Bifidobacterium animalis Ameliorate Escherichia coli-Induced IPEC-J2 Cell Damage via Inhibiting Apoptosis and Restoring Autophagy. Microorganisms 2021;9:2363. [PMID: 34835488 DOI: 10.3390/microorganisms9112363] [Reference Citation Analysis]
13 Lu W, Deng Y, Fang Z, Zhai Q, Cui S, Zhao J, Chen W, Zhang H. Potential Role of Probiotics in Ameliorating Psoriasis by Modulating Gut Microbiota in Imiquimod-Induced Psoriasis-Like Mice. Nutrients 2021;13:2010. [PMID: 34207960 DOI: 10.3390/nu13062010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Sun D, Ge X, Tang S, Liu Y, Sun J, Zhou Y, Luo L, Xu Z, Zhou W, Sheng J. Bacterial Characteristics of Intestinal Tissues From Patients With Crohn's Disease. Front Cell Infect Microbiol 2021;11:711680. [PMID: 34869050 DOI: 10.3389/fcimb.2021.711680] [Reference Citation Analysis]